Preview

Biological Products. Prevention, Diagnosis, Treatment

Advanced search

Experimental evaluation of the possibility of determining bacterial endotoxins in typhoid Vi polysaccharide vaccines using the gel-clot test

https://doi.org/10.30895/2221-996X-2023-23-4-570-583

Abstract

Scientific relevance. Currently, only the rabbit pyrogen test is used to test the Vianvac® typhoid Vi polysaccharide vaccine for pyrogenicity. As part of the product specification file, the gel-clot test for bacterial endotoxins (BE) will improve the reliability of quality control, as well as harmonise the requirements for the vaccine with the requirements outlined for this group of medicinal products by leading world pharmacopoeias.

Aim. This study aimed at an experimental assessment of the applicability of the gel-clot test to the quantification of BE in the typhoid Vi polysaccharide vaccine.

Materials and methods. This study used samples from 5 batches of the typhoid Vi polysaccharide vaccine (0.5 mL/dose, solution for subcutaneous injection), LAL and TAL reagents. The analysis included the gel-clot test and the pyrogenicity test according to the State Pharmacopoeia of the Russian Federation (OFS.1.2.4.0006.15 and OFS.1.2.4.0005.15, respectively).

Results. According to calculations, the BE limit for the tested vaccine was 96 EU/mL, and the maximum valid dilution (MVD) was 3200. The authors determined the regulatory requirements for typhoid Vi polysaccharide vaccine quality in terms of BE (not more than 48 EU/dose). The in vitro BE tests were positive at vaccine dilutions of 1/16 to 1/32 and negative at 1/64 to 1/256. The authors selected and validated a working vaccine dilution of 1/128. The BE content measured in the tested samples ranged from 0.24 to 0.48 EU/dose. The in vivo pyrogen tests were positive at dilutions of 1/16 to 1/128 and negative at 1/256 in all experiments with samples from 5 vaccine batches at dilutions ranging from 1/16 to 1/256.

Conclusions. This study has experimentally proven that the gel-clot test can quantify BE in the typhoid Vi polysaccharide vaccine. The authors have recommended introducing the gel-clot BE test in the monograph of the State Pharmacopoeia of the Russian Federation on the typhoid Vi polysaccharide vaccine (FS.3.3.1.0012.15).

About the Authors

M. V. Abramtseva
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Marina V. Abramtseva

8/2 Petrovsky Blvd, Moscow 127051



N. S. Alekhina
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Natalya S. Alekhina

8/2 Petrovsky Blvd, Moscow 127051



E. D. Kolyshkina
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Elena D. Kolyshkina

8/2 Petrovsky Blvd, Moscow 127051



References

1. Gorman A, Golovanov AP. Lipopolysaccharide structure and the phenomenon of low endotoxin recovery. Eur J Pharm Biopharm. 2022;180:289–307. https://doi.org/10.1016/j.ejpb.2022.10.006

2. Kim JH, Jung K, Kim J, Lee J, Kim H, Song H, et al. Development of a rabbit monocyte activation test as an alternative to the rabbit pyrogen test and its application in the analysis of plasma-derived products. Biologicals. 2021;71:20–30. https://doi.org/10.1016/j.biologicals.2021.04.003

3. Fennrich S, Hennig U, Toliashvili L, Schlensak C, Wendwl HP, Stoppelkamp S. More than 70 years of pyrogen detection: current state and future perspectives. Altern Lab Anim. 2016;44(3):239–53. https://doi.org/10.1177/026119291604400

4. Bu R, Deng X, Cao Y, Jin J, Mai B, Meng K, et al. Effect of different sample treatment methods on Low Endotoxin Recovery phenomenon. J Microbiol Methods. 2021;186:106241. https://doi.org/10.1016/j.mimet.2021.106241

5. Spoladore J, Gimenes I, Bachinski R, Negherbon JP, Hartung T, Granjeiro JM, et al. Standardized pyrogen testing of medical products with the bacterial endotoxin test (BET) as a substitute for rabbit pyrogen testing (RPT): a scoping review. Toxicol in Vitro. 2021;74:105160. https://doi.org/10.1016/j.tiv.2021.105160

6. Novitsky TJ. BET vs. PT non-endotoxin pyrogens. LAL Update.2002;20(2):1–4.

7. Boucher PE. A framework for evaluating nonclinical safety of novel adjuvants and adjuvanted preventive vaccines. In: Schijns VEJC, O’Hagan DT, eds. Immunopotentiators in Modern Vaccines. 2nd ed. Fort Washington, PA: Academic Press; 2017. P. 445–76. https://doi.org/10.1016/B978-0-12-804019-5.00022-0

8. Neugodova NP, Ryabtseva MS, Sapozhnikova GA. Basic requirements for biological criteria in drug quality evaluation. Validation of biological control methods. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2016;(3):3–8 (In Russ.). EDN: WKNSQZ

9. Fingola FF, Albertino SRG, de Abrantes SMP, Zamith HPS. Proposed reduction of the in vivo pyrogen test by the in vitro LAL assay for the quality control of anticrotallic, antiscorpion, antirabies and antitetanus sera. Toxicol in Vitro. 2019;59:292–9. https://doi.org/10.1016/j.tiv.2019.04.031

10. Shapovalova OV, Neugodova NP, Sapozhnikova GA. Choosing bacterial endotoxin detection method. Antibiotics and Chemotherapy. 2018;63(5–6):43–5 (In Russ.). EDN: XVVINF

11. Burguet N, Brito LC. Validación del método LAL para determinar endotoxinas bacterianas en el inyectable heparina sódica. VacciMonitor. 2012;21(3):32–6 (In Span.).

12. Dawson ME. Preliminary testing. LAL Update. 1996;14(1):1–4.

13. Shapovalova OV, Neugodova NP, Dolgova GV, Sapozhnikova GA. Methodological approaches to the elaboration of “Bacterial endotoxins” index in the pharmaceutical substances. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2012;(2):47–50 (In Russ.). EDN: RWVTUZ


Supplementary files

Review

For citations:


Abramtseva M.V., Alekhina N.S., Kolyshkina E.D. Experimental evaluation of the possibility of determining bacterial endotoxins in typhoid Vi polysaccharide vaccines using the gel-clot test. Biological Products. Prevention, Diagnosis, Treatment. 2023;23(4):570-583. (In Russ.) https://doi.org/10.30895/2221-996X-2023-23-4-570-583

Views: 818


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2221-996X (Print)
ISSN 2619-1156 (Online)